JP2024069192A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024069192A5 JP2024069192A5 JP2024015822A JP2024015822A JP2024069192A5 JP 2024069192 A5 JP2024069192 A5 JP 2024069192A5 JP 2024015822 A JP2024015822 A JP 2024015822A JP 2024015822 A JP2024015822 A JP 2024015822A JP 2024069192 A5 JP2024069192 A5 JP 2024069192A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- subject
- administration
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677943P | 2018-05-30 | 2018-05-30 | |
| US62/677,943 | 2018-05-30 | ||
| US201862771398P | 2018-11-26 | 2018-11-26 | |
| US62/771,398 | 2018-11-26 | ||
| US201962822376P | 2019-03-22 | 2019-03-22 | |
| US62/822,376 | 2019-03-22 | ||
| GC2019-37663 | 2019-05-28 | ||
| GC201937663 | 2019-05-28 | ||
| PCT/US2019/034523 WO2019232130A1 (en) | 2018-05-30 | 2019-05-30 | Methods for increasing sepiapterin plasma exposure |
| JP2020566655A JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Division JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024069192A JP2024069192A (ja) | 2024-05-21 |
| JP2024069192A5 true JP2024069192A5 (https=) | 2024-08-22 |
| JP7841005B2 JP7841005B2 (ja) | 2026-04-06 |
Family
ID=68699037
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Active JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
| JP2024015822A Active JP7841005B2 (ja) | 2018-05-30 | 2024-02-05 | セピアプテリン血漿曝露を増加させるための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Active JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US11617752B2 (https=) |
| EP (2) | EP4454704A3 (https=) |
| JP (2) | JP7502197B2 (https=) |
| CN (1) | CN112703002A (https=) |
| AU (2) | AU2019277382B2 (https=) |
| CA (1) | CA3102106A1 (https=) |
| DK (1) | DK3801536T3 (https=) |
| ES (1) | ES2986920T3 (https=) |
| FI (1) | FI3801536T3 (https=) |
| HR (1) | HRP20241213T1 (https=) |
| HU (1) | HUE068589T2 (https=) |
| LT (1) | LT3801536T (https=) |
| MD (1) | MD3801536T2 (https=) |
| MX (2) | MX2020012979A (https=) |
| PL (1) | PL3801536T3 (https=) |
| PT (1) | PT3801536T (https=) |
| RS (1) | RS65874B1 (https=) |
| SI (1) | SI3801536T1 (https=) |
| SM (1) | SMT202400430T1 (https=) |
| WO (1) | WO2019232130A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA46973A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Polymorphes de sépiaptérine et leurs sels |
| MA46972A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Forme polymorphe de sépiaptérine |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| FI3801536T3 (fi) | 2018-05-30 | 2024-08-29 | Ptc Therapeutics Mp Inc | Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi |
| EP3801534B1 (en) | 2018-05-30 | 2026-02-18 | PTC Therapeutics MP, Inc. | Treatment of phenylketonuria with sepiapterin |
| EP4093405A1 (en) * | 2020-01-24 | 2022-11-30 | PTC Therapeutics MP, Inc. | Methods for treating parkinson's disease with sepiapterin |
| WO2021168206A1 (en) * | 2020-02-19 | 2021-08-26 | Musc Foundation For Research Development | L-sepiapterin and methods of use for treating diseases and disorders |
| IL305037A (en) * | 2021-02-09 | 2023-10-01 | Ptc Therapeutics Mp Inc | Methods of treating glioblastomas with spiafatrin |
| WO2022173823A1 (en) * | 2021-02-09 | 2022-08-18 | Ptc Therapeutics Mp, Inc. | Methods for treating covid-19 with sepiapterin |
| CN120732846A (zh) * | 2025-04-09 | 2025-10-03 | 中南大学湘雅医院 | 吲哚乙酸在制备预防或治疗高血压产品中的用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5925323A (ja) | 1982-03-03 | 1984-02-09 | 鐘淵化学工業株式会社 | プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤 |
| US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| JP2002515965A (ja) | 1995-08-18 | 2002-05-28 | ダブリュー． ランドリ，ドナルド | 抗体触媒反応の調節による有機化合物の検出 |
| US6036949A (en) | 1998-03-05 | 2000-03-14 | Amarillo Biosciences, Inc. | Treatment of fibromyalgia with low doses of interferon |
| US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
| FR2859996B1 (fr) | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
| WO2005048926A2 (en) | 2003-11-13 | 2005-06-02 | The General Hospital Corporation | Methods for treating pain |
| EP1687308B1 (en) | 2003-11-17 | 2019-06-12 | Merck & Cie | Process for preparating (6R)-L-erythrotetrahydrobiopterin hydrochloride crystalline form B from other crystalline forms |
| PL1708690T3 (pl) | 2003-11-17 | 2017-01-31 | Biomarin Pharmaceutical Inc. | Leczenie fenyloketonurii za pomocą BH4 |
| JP5184783B2 (ja) | 2003-11-17 | 2013-04-17 | バイオマリン ファーマシューティカル インコーポレイテッド | テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法 |
| KR20070084270A (ko) | 2004-11-17 | 2007-08-24 | 바이오마린 파머수티컬 인크. | 안정한 정제 제형물 |
| JP2008523090A (ja) | 2004-12-08 | 2008-07-03 | バイオマリン ファーマシューティカル インコーポレイテッド | 新生児肺高血圧症の治療のための方法および組成物 |
| BRPI0609421B1 (pt) | 2005-04-28 | 2021-06-01 | Shiratori Pharmaceutical Co., Ltd. | Processos para produção de um composto 1,1-bis-alquil sulfonila, para produção de um composto aldeído, e para produção de um derivado de hidrazona |
| US20080075666A1 (en) | 2006-08-25 | 2008-03-27 | Dudley Samuel C Jr | Methods and compositions for treating diastolic dysfunction |
| LT2545939T (lt) | 2007-04-11 | 2021-03-10 | Biomarin Pharmaceutical Inc. | Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu |
| WO2010017570A2 (de) | 2008-08-12 | 2010-02-18 | Orpha Swiss Gmbh | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
| EP2562176B1 (en) * | 2010-04-22 | 2018-08-15 | Nihon University | Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| CN103458900A (zh) | 2011-03-01 | 2013-12-18 | 鲁必康研究私人有限公司 | 四氢生物蝶呤的稳定组合物 |
| US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
| CN104736539B (zh) | 2012-05-07 | 2017-09-01 | 白鸟制药株式会社 | 墨蝶呤和四氢乳酰蝶呤的制造法 |
| EP3213062B1 (en) * | 2014-10-31 | 2020-02-12 | Children's Medical Center Corporation | Methods and assays relating to sepiapterin reductase inhibition |
| MA46973A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Polymorphes de sépiaptérine et leurs sels |
| MA46972A (fr) | 2016-11-29 | 2019-10-09 | Censa Pharmaceuticals Inc | Forme polymorphe de sépiaptérine |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| WO2019102315A1 (en) * | 2017-11-23 | 2019-05-31 | Semiconductor Energy Laboratory Co., Ltd. | Display device and electronic device |
| EP3801534B1 (en) * | 2018-05-30 | 2026-02-18 | PTC Therapeutics MP, Inc. | Treatment of phenylketonuria with sepiapterin |
| AU2019277372B2 (en) | 2018-05-30 | 2024-12-19 | Ptc Therapeutics Mp, Inc. | Pharmaceutically acceptable salts of sepiapterin |
| FI3801536T3 (fi) | 2018-05-30 | 2024-08-29 | Ptc Therapeutics Mp Inc | Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi |
| IL290321B1 (en) | 2019-08-05 | 2026-04-01 | Ptc Therapeutics Inc | Use of spiapterin and its metabolites for radiation exposure treatment |
| IL291565B1 (en) | 2019-09-25 | 2026-04-01 | Ptc Therapeutics Inc | Method for treating phenylalanine irregularity |
-
2019
- 2019-05-30 FI FIEP19811888.7T patent/FI3801536T3/fi active
- 2019-05-30 CN CN201980050839.7A patent/CN112703002A/zh active Pending
- 2019-05-30 MX MX2020012979A patent/MX2020012979A/es unknown
- 2019-05-30 HR HRP20241213TT patent/HRP20241213T1/hr unknown
- 2019-05-30 SI SI201930841T patent/SI3801536T1/sl unknown
- 2019-05-30 LT LTEPPCT/US2019/034523T patent/LT3801536T/lt unknown
- 2019-05-30 EP EP24187175.5A patent/EP4454704A3/en active Pending
- 2019-05-30 PL PL19811888.7T patent/PL3801536T3/pl unknown
- 2019-05-30 US US17/059,719 patent/US11617752B2/en active Active
- 2019-05-30 JP JP2020566655A patent/JP7502197B2/ja active Active
- 2019-05-30 EP EP19811888.7A patent/EP3801536B1/en active Active
- 2019-05-30 RS RS20240943A patent/RS65874B1/sr unknown
- 2019-05-30 CA CA3102106A patent/CA3102106A1/en active Pending
- 2019-05-30 MD MDE20210340T patent/MD3801536T2/ro unknown
- 2019-05-30 HU HUE19811888A patent/HUE068589T2/hu unknown
- 2019-05-30 AU AU2019277382A patent/AU2019277382B2/en active Active
- 2019-05-30 PT PT198118887T patent/PT3801536T/pt unknown
- 2019-05-30 WO PCT/US2019/034523 patent/WO2019232130A1/en not_active Ceased
- 2019-05-30 ES ES19811888T patent/ES2986920T3/es active Active
- 2019-05-30 DK DK19811888.7T patent/DK3801536T3/da active
- 2019-05-30 SM SM20240430T patent/SMT202400430T1/it unknown
-
2020
- 2020-11-30 MX MX2024005935A patent/MX2024005935A/es unknown
-
2023
- 2023-03-31 US US18/129,177 patent/US12329757B2/en active Active
-
2024
- 2024-02-05 JP JP2024015822A patent/JP7841005B2/ja active Active
-
2025
- 2025-02-06 AU AU2025200814A patent/AU2025200814A1/en active Pending
- 2025-05-13 US US19/206,193 patent/US20260091037A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069192A5 (https=) | ||
| EP3426240B1 (en) | Mixed salt compositions for producing elevated and sustained ketosis | |
| JP2021525729A5 (https=) | ||
| JP2024074963A5 (https=) | ||
| JP2024063143A5 (https=) | ||
| JPS61277618A (ja) | 自閉症治療剤 | |
| JP2022523513A5 (https=) | ||
| JP2018507243A5 (https=) | ||
| FI3801536T3 (fi) | Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi | |
| CN103298464A (zh) | 复方组合物 | |
| JP2023535744A5 (https=) | ||
| JPS62111924A (ja) | 恐慌障害の軽減剤 | |
| JP2022549834A5 (https=) | ||
| FI4034122T3 (fi) | Menetelmiä hyperfenyylialaninemian hoitamiseksi | |
| JP2021525746A5 (https=) | ||
| KR20240032789A (ko) | 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물 | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| US20060233892A1 (en) | Topiramate compositions for treatment of headache | |
| MX2024006271A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023502941A5 (https=) | ||
| JP2001518481A (ja) | 経口投与のためのセロトニン含有製剤及びその使用方法 | |
| Oettmeier et al. | The procainebase-infusion: 20 years of experience of an alternative use with several therapeutical effects | |
| RU2709500C1 (ru) | Фармацевтическая композиция для парентерального капельного введения | |
| Bardsley | Chronic respiratory failure in COPD: is there a place for a respiratory stimulant? | |
| RU2412701C2 (ru) | Способ снижения непереносимости противотуберкулезных препаратов |